Sarah Cannon — Nashville, Tennessee

Sarah Cannon is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Sarah Cannon has participated in 19 clinical trials with 3 currently active.

Therapeutic areas: ER+ HER2- Advanced Breast Cancer, Early Cancer Detection, Metastatic Solid Tumor.

Sponsors: AstraZeneca, Exact Sciences Corporation, Hutchmed.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon?

Sarah Cannon has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon conducted?

Sarah Cannon has 19 clinical trials on record, with 3 currently active. Their work covers ER+ HER2- Advanced Breast Cancer, Early Cancer Detection, Metastatic Solid Tumor.

Is Sarah Cannon accredited by Crixeo Health?

Yes — Sarah Cannon holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.